Literature DB >> 19120723

Can an angiotensin receptor blocker be used in a patient in whom angioedema developed with an angiotensin-converting enzyme inhibitor?

Debbie L Cohen1, Raymond R Townsend.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19120723      PMCID: PMC8672982          DOI: 10.1111/j.1751-7176.2008.00042.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  12 in total

1.  Investigation of angioedema associated with the use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.

Authors:  Baiju Malde; Jane Regalado; Paul A Greenberger
Journal:  Ann Allergy Asthma Immunol       Date:  2007-01       Impact factor: 6.347

2.  Incidence and characteristics of angioedema associated with enalapril.

Authors:  John B Kostis; Harold J Kim; James Rusnak; Thomas Casale; Allen Kaplan; Jonathan Corren; Elliott Levy
Journal:  Arch Intern Med       Date:  2005-07-25

3.  Plasma bradykinin in angio-oedema.

Authors:  J Nussberger; M Cugno; C Amstutz; M Cicardi; A Pellacani; A Agostoni
Journal:  Lancet       Date:  1998-06-06       Impact factor: 79.321

Review 4.  Angiotensin-converting enzyme (ACE) inhibitors and angio-oedema.

Authors:  R A Sabroe; A K Black
Journal:  Br J Dermatol       Date:  1997-02       Impact factor: 9.302

Review 5.  Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy. A review of the literature and pathophysiology.

Authors:  Z H Israili; W D Hall
Journal:  Ann Intern Med       Date:  1992-08-01       Impact factor: 25.391

6.  Multicenter study of patients with angiotensin-converting enzyme inhibitor-induced angioedema who present to the emergency department.

Authors:  Aleena Banerji; Sunday Clark; Michelle Blanda; Frank LoVecchio; Brian Snyder; Carlos A Camargo
Journal:  Ann Allergy Asthma Immunol       Date:  2008-04       Impact factor: 6.347

7.  Angioedema associated with angiotensin-converting enzyme inhibitor use: outcome after switching to a different treatment.

Authors:  Marco Cicardi; Lorenza C Zingale; Luigi Bergamaschini; Angelo Agostoni
Journal:  Arch Intern Med       Date:  2004-04-26

8.  Angioedema in the emergency department: the impact of angiotensin-converting enzyme inhibitors.

Authors:  E C Pigman; J L Scott
Journal:  Am J Emerg Med       Date:  1993-07       Impact factor: 2.469

9.  Aminopeptidase P in individuals with a history of angio-oedema on ACE inhibitors.

Authors:  Albert Adam; Massimo Cugno; Giuseppe Molinaro; Melissa Perez; Yves Lepage; Angelo Agostoni
Journal:  Lancet       Date:  2002-06-15       Impact factor: 79.321

10.  Telmisartan, ramipril, or both in patients at high risk for vascular events.

Authors:  Salim Yusuf; Koon K Teo; Janice Pogue; Leanne Dyal; Ingrid Copland; Helmut Schumacher; Gilles Dagenais; Peter Sleight; Craig Anderson
Journal:  N Engl J Med       Date:  2008-03-31       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.